A devastating reality emerges from global health data: acute kidney injury strikes millions worldwide, yet access to life-saving interventions depends largely on geographic lottery. This comprehensive epidemiological analysis exposes how medical advances remain concentrated in wealthy nations while vulnerable populations face preventable mortality. The syndrome affects both adults and children across diverse clinical settings, accelerating progression to chronic kidney disease and driving substantial healthcare resource consumption. Electronic health record integration, novel biomarkers, and structured care protocols have demonstrated measurable improvements in patient outcomes, with artificial intelligence showing promise for early detection and intervention optimization. However, these technological advances concentrate primarily within high-income healthcare systems, leaving vast populations underserved. The research reveals significant heterogeneity in patient characteristics, care processes, and environmental factors that influence treatment delivery and survival rates across different regions. Despite decades of research establishing standardized diagnostic criteria and staging systems, treatment options remain largely supportive rather than curative, highlighting persistent knowledge gaps in therapeutic development. The 5R management framework—encompassing risk assessment, recognition, response protocols, renal support, and rehabilitation—shows uneven implementation globally. This disparity creates a two-tier system where patients in resource-limited settings face substantially higher mortality rates for the same condition. The analysis underscores an urgent imperative for global health equity initiatives focused on standardizing care delivery and ensuring universal access to proven interventions for this common yet potentially reversible medical emergency.